Krystal BiotechKRYS

那斯達克 · USD
268.90
+7.49
(+2.87%)
盤中 01/13 12:07 (UTC+8)
01/13 12:07 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • 0.09
  • 0.42
  • 0.45
  • 0.70
  • 0.84
  • 0.91
  • 0.88
  • 0.96
  • 0.98
icon
  • -
  • -
  • 392.55
  • 7.37
  • 55.33
  • 19.29
  • 8.70
  • -3.24
  • 8.91
  • 1.83
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
97,800
96,042
88,183
91,139
83,841
70,285
45,250
42,143
8,556
-
營業成本
4,2647,1655,0284,9496,6846,0092,4192,871223-
營業毛利
93,536
88,877
83,155
86,190
77,157
64,276
42,831
39,272
8,333
-
營業費用
51,99449,571-44,86854,72455,70949,51536,13434,32738,048
研發費用
14,58514,41114,25513,52113,51115,58210,95711,37010,62912,144
推銷及管理費用
37,40935,16032,72331,34728,71327,62726,05824,76423,69825,904
非經常性項目費用
----12,50012,50012,500---
其他營業費用
----------
營業利益
41,542
39,306
36,177
41,322
22,433
8,567
-6,684
3,138
-25,994
-38,048
其他收入及費用
6,4267,4697,4207,2887,3357,4797,6167,519106,7414,838
利息費用
----------
稅前純益
47,968
46,775
43,597
48,610
29,768
16,046
932
10,657
80,747
-33,210
所得稅
-31,3968,4417,8643,1312,589477-1,965--
稅後純益
79,364
38,334
35,733
45,479
27,179
15,569
932
8,692
80,747
-33,210
基本每股稅後盈餘(元)
2.741.331.241.580.950.540.03-2.88-1.25
稀釋每股稅後盈餘(元)
2.661.291.201.530.910.530.030.313.08-1.24
基本平均股數(千股)
28953.0028910.0028815.0028755.0028716.0028598.0028295.00-28042.0026657.00
稀釋平均股數(千股)
29833.0029749.0029871.0029883.0029902.0029637.0029291.00-28892.0026657.00
還原基本每股稅後盈餘(元)
2.741.331.241.580.950.540.03-2.88-1.25
還原稀釋每股稅後盈餘(元)
2.661.291.201.530.910.530.030.313.08-1.24
還原基本平均股數(千股)
28,95328,91028,81528,75528,71628,59828,295-28,04226,657
還原稀釋平均股數(千股)
29,83329,74929,87129,88329,90229,63729,291-28,89226,657
EBITDA(千元)
49,25549,23544,77849,99430,86617,7651,73911,81781,573-32,172

大家都在看

HOT